Clinical Trials

We investigate new products (drugs, nutraceuticals, etc.) and medical technologies through clinical trials with patients suffering from osteoarthritis.

Despite the high prevalence of this disease, the therapeutic options available are few and most address drug treatment from a symptomatic point of view only, for example, through the administration of analgesics and non-steroidal anti-inflammatory drugs (NSAIDs), whose chronic use in elderly people it entails important cardiovascular, gastrointestinal, hepatic and renal side effects.

At OAFI we are currently collaborating in the following clinical trials:

A new injectable treatment in the population with knee osteoarthritis.

Do you want to receive more information or do you want to participate in these studies?

A drug for the improvement of hand osteoarthritis, a pathology for which, to date, there are no specific treatments.

Do you want us to participate in a clinical trial with patients with osteoarthritis?

“The OAFI Foundation was born to give a voice to the millions of people who suffer from a disease as devastating as osteoarthritis. With an innovative, creative and action mentality, at OAFI we have pioneering projects for treatment and research. Our motto is: WE MAKE THINGS HAPPEN!”

Dr. Josep Vergés
“The patient is the raison d'être of the International Osteoarthritis Foundation (OAFI) and is the engine that drives us to work and move forward. Being an OAFI volunteer means taking sides and helping to carry out the initiatives promoted in favor of other patients and the Society in terms of health.”

Maria Teresa Vergés
“Communication is one of the central pillars of OAFI. As patient representatives, it is our duty to bring their voice to the public sphere and, in turn, transfer them the necessary tools to better understand their disease. Our role as disseminators and awareness of osteoarthritis is essential to help them understand and accept it. In this way, we will be able to improve their quality of life and prevent future cases of the pathology.”

Cristina Nova
“In order to develop the social activity of the foundation, it is important to raise funds that allow us to act autonomously and independently. From the foundation we have to thank all the people and companies that, with their contributions, allow us to continue working every day to help people who suffer from osteoarthritis and other oestoarticular pathologies.”

Marco Bibas
“The OAFI Foundation's R&D department plays a crucial role in advancing knowledge and treatment of joint health, especially osteoarthritis. We drive the generation of new scientific knowledge, we explore new therapies and treatments, and we promote the exchange of knowledge, resources and data with organizations and researchers around the world, with the aim of improving the lives of those who suffer from this disease.”

Nina Martínez
"Non-Governmental Organizations (NGO) and Non-Profit Organizations (ONL), in order to undertake actions that transform and improve society, we need the Corporate Social Responsibility of companies, since financing is necessary and in application of ethics and transparency enhances donor organizations.”

Dr. Baquero Úbeda